GlassScriptPhysician profile
Anthony J Lacorte
NPI 1104889963
$2,744.51
in general payments reported to CMS, 2019-2025
19 companies · $420 in 2025
The $420 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.15 · 2023: $826 · 2024: $1,475 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,721.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $744.44 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $582.42 | 2023-2025 | |
| Novo Nordisk INC | $368.49 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $192.93 | 2023-2024 | Mounjaro, Zepbound, Trulicity |
| Pfizer INC. | $170.72 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $166.39 | 2023-2024 | Rexulti |
| Nestle Healthcare Nutrition INC. | $125.00 | 2023 | |
| Amgen INC. | $85.80 | 2024-2025 | Repatha, Repatha, Otezla |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $68.00 | 2024-2025 | Caplyta |
| Medtronic, INC. | $43.97 | 2025 | Inceptiv |
| Kowa Pharmaceuticals America, INC. | $30.95 | 2023 | Seglentis, Livalo |
| Bayer Healthcare Pharmaceuticals INC. | $26.90 | 2025 | |
| Astellas Pharma US INC | $25.28 | 2024 | Veozah |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.15 | 2019 | |
| Averitas Pharma INC. | $22.09 | 2023 | Qutenza |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.79 | 2023 | Synjardy, Tradjenta, Jardiance |
| Exact Sciences Corporation | $18.61 | 2025 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $16.13 | 2023 | Auvelity |
| Merck Sharp & Dohme LLC | $13.45 | 2024 | Capvaxive, M-M-R II, Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Lacorte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.